Related Experiment Video
Updated: Jun 4, 2025
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
10.7K
Inflammasomes in neurodegenerative diseases
Qianchen Wang1, Songwei Yang2, Xuan Zhang3
1Department of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Translational Neurodegeneration
|December 22, 2024
Summary
Inflammasomes, key innate immune sensors, activate in neurodegenerative diseases due to misfolded proteins. This leads to inflammation and cell death, highlighting inflammasomes as potential therapeutic targets.
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Inflammasomes are innate immune sensors recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).
- Misfolded proteins like beta-amyloid and alpha-synuclein in neurodegenerative diseases trigger inflammasome activation.
- Activated inflammasomes release pro-inflammatory cytokines (IL-1β, IL-18) and induce pyroptosis, exacerbating neuroinflammation.
Purpose of the Study:
- To review the role of inflammasomes in neurodegenerative diseases.
- To focus on the canonical inflammasome activation pathway in these conditions.
- To discuss inflammasomes as potential therapeutic targets for neurodegenerative disorders.
Main Methods:
- Literature review focusing on inflammasome activation in neurodegenerative diseases.
- Analysis of evidence for canonical inflammasome pathway involvement.
- Synthesis of current understanding of inflammasome roles and therapeutic potential.
Main Results:
- Inflammasome activation is increasingly implicated in the pathogenesis of neurodegenerative diseases.
- Canonical inflammasome pathways are frequently involved in disease-associated inflammasome activation.
- Inflammasome-induced pyroptosis and cytokine release contribute significantly to neuroinflammation.
Conclusions:
- Inflammasomes play a critical role in neuroinflammation associated with neurodegenerative diseases.
- Understanding inflammasome activation mechanisms is crucial for developing effective treatments.
- Targeting inflammasomes offers a promising therapeutic strategy for neurodegenerative conditions.
Related Concept Videos
01:24Caspases
12.3K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.3K
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
01:38Inflammation
52.5K
Overview
52.5K
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:17Phagocytosis of Apoptotic Cells
3.7K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.7K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K